HCF
0.037
105.6%
SRN
0.001
-50%
MEU
0.13
83.1%
FBR
0.003
-40%
CTN
0.003
50%
SPX
0.002
-33.3%
CHM
0.004
33.3%
NES
0.006
-25%
ROG
0.004
33.3%
MIO
0.02
-23.1%
WHK
0.009
28.6%
A11
0.155
-20.5%
ALV
0.083
25.8%
CDE
0.008
-20%
STV
0.011
22.2%
MOH
0.008
-20%
BLU
0.006
20%
RLG
0.004
-20%
KKO
0.067
19.6%
SPQ
0.009
-18.2%
LKE
0.094
19%
NFL
0.115
-17.9%
TSK
0.13
18.2%
GRL
0.014
-17.6%
GLL
0.007
16.7%
TRU
0.014
-17.6%
HMX
0.028
16.7%
AYT
0.005
-16.7%
PLC
0.007
16.7%
VAR
0.005
-16.7%
RAD
0.021
16.7%
LMS
0.405
-16.5%
AXI
0.015
15.4%
FTI
0.185
-15.9%
FEX
0.5
14.9%
ACP
0.023
-14.8%
RNT
0.055
14.6%
RGL
0.006
-14.3%
HMI
0.04
14.3%
SMM
0.012
-14.3%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

The Stock Network

The Stock Network (TSN) is your trusted source for ASX stock market news, key trends, and investment insights. Stay tuned for the latest reports, expert market analysis, and IPO updates.

ASX & US stock news headlines

Immutep Limited (ASX:IMM, NASDAQ:IMMP) has inked a deal to commercialise its oncology drug Eftilagimod Alfa (efti). The strategic collaboration is with India-based pharmaceutical group Dr. Reddy’s Laboratories (BSE:500124, NSE: DRREDDY, NYSE: RDY). Dr. Reddy’s will get exclusive rights to roll out efti across most global markets excluding North America, Europe, Japan and Greater China. In return, Immutep will receive an upfront USD $20 million (~AUD $30.2 million), also plus eligibility for up to USD $349.5 million (~AUD $528.4 million) in milestone payments, along with double-digit royalties. Efti is designed to activate the immune system to fight cancer, currently in Phase III trials for lung cancer and being tested across other tumour types

#health #stocks #money #fintok #biotech
Copper has quietly surged to all-time record highs, yet the conversation among investors remains unusually muted. Against tightening supply, structural deficits, and accelerating demand from electrification, AI-driven data centres, and global manufacturing recovery, copper is emerging as an increasingly important and strategic critical metal.

Kincora Copper (ASX:KCC, TSXV:KCC) Kincora President and CEO, Sam Spring, joins Lel Smits from The Stock Network to explore why copper’s price breakout is not a temporary spike, but a symptom of a market fundamentally short of metal, with UBS forecasting persistent deficits, constrained production growth, and structurally rising demand into 2026 and beyond.

📈 Record copper prices
🗓️ 2026 supply squeeze
⚒️ Gold and copper price correlation
The price of copper is surging to record highs as demand shifts at global levels. Every electrical vehicle needs up to four times more copper than a petrol car, renewable energy needs copper and AI data centres are copper-intensive by design. Supply can’t keep up and Morgan Stanley says this is set to continue into 2026. Copper has become essential to energy, transport, computing and national grids and the world can’t dig it up fast enough. Prices aren’t just climbing, they’re breaking records. As one analyst said, “Lithium may be the spark, but copper is the backbone to electrification.”

#fintok #mining #money #stocks #copper
Vection Technologies (ASX:VR1, OTC:VCTNY, FRA:S1X) has been recognised as a finalist in the InnovationAus 2025 Awards for Excellence under the AI Technology category. A testament to the company’s ongoing commitment to pushing the boundaries of immersive technology, artificial intelligence, and enterprise digital transformation.

✨ End-to-end immersive technology ecosystem
✨ AI-powered solutions that bridge digital and physical worlds
✨ A commitment to redefining how organisations design, collaborate, and engage
Shares in European Lithium (ASX:EUR, FRA:PF8, OTC:EULIF) are up more than 300% this year on the back of significant resource development activity, major funding inflows and continued advancement of high-value critical minerals assets including rare earths in Greenland and the largest lithium mine in Europe, based in Ukraine. Joining The Stock Network’s Lel Smits, Executive Chairman Tony Sage explains how European Lithium is building a globally diversified critical minerals portfolio, supported by a strengthening balance sheet and expanded drilling programs.

⚒️ Transformational quarter backed by strong cash position
🪨 Drilling momentum at the Tanbreez Rare Earth Project, Greenland
⛰️ Expanding a multi-region critical minerals portfolio
@netflix Inc (NASDAQ:NFLX) has done a deal to buy @warnerbros. for more than AUD $100 billion, but not everyone is happy about it. The $425 billion Nasdaq listed streaming company announced the merger last week but some say it should be blocked. The backlash is for a few reasons - firstly as Netflix will gain control of one of Hollywood's most prized content companies. The Writers Guild of America says this is about, "The world’s largest streaming company swallowing one of its biggest competitors, and it's what antitrust laws were designed to prevent." But what do you think? Is this a good deal for Netflix - and will you be watching more?

#fintok #stock #tech #nasdaq #wallstreet
Shares in NextDC (ASX:NXT) have lifted after inking a deal with ChatGPT's owner OpenAI. Under the deal the $9 billion Aussie data centre company NextDC will build a new data centre in Sydney for US based OpenAI. NextDC says the deal is about building the next generation of sovereign AI infrastructure in Australia

#fintok #ai #stocks #tech #chatGPT
Saluda Medical has listed on the ASX with a ticker code of SLD. The company is redefining the standard of care in spinal cord stimulation (SCS) with its Evoke System - the world’s first ECAP-controlled, closed-loop SCS therapy. The Evoke System delivers personalised, data-driven therapy by automatic ally adjusting stimulation over four million times per day, based on real-time neural signals unique to each patient.

Website: https://www.saludamedical.com/
Directors: President & CEO – Barry Regan; Chair – Doug Godshall; CFO – James Erickson; Non-Executive Directors – Geoffrey Brooke, Robert Faulkner, Catherine Livingstone, Robert Palmisano
Media: The Stock Network, Lel Smits

ASX announcement news

TMS

TEM

VR1

ALY

PE1

AVM

AQX

MVF

VMS

Sharing stock market news

European Lithium (ASX:EUR): Building a critical minerals portfolio through resource milestones

Vection Technologies (ASX:VR1, OTC:VCTNY, FRA:S1X): Accelerating APAC expansion

Listing on stock exchanges

Stock & market analysis.

FinTok

Stock & market analysis

IPOs

Listing on stock exchanges

Resources stocks & mining stocks

Noticeboard

ASX 200

Last Update: 11-12-2025
Today's Date: 2025-12-11
Market Status: Closed
Last Update: 11-12-2025

Top Gainers

HCF0.037 105.6%
MEU0.13 83.1%
CTN0.003 50%
CHM0.004 33.3%

Biggest Losers

SRN0.001 -50%
FBR0.003 -40%
SPX0.002 -33.3%
NES0.006 -25%

By proceeding, you can confirm you understand that we handle personal informational in accordance with our Privacy Policy